Boron neutron capture therapy for locally recurrent head and neck squamous cell carcinoma: An analysis of dose response and survival.


Department of Oncology, Helsinki University Hospital and University of Helsinki, Finland. Electronic address: [Email]


Head and neck squamous cell carcinoma (HNSCC) that recurs locally is a therapeutic challenge. We investigated the efficacy of boron neutron capture therapy (BNCT) in the treatment of such patients and the factors associated with treatment response and survival.


Boron neutron capture therapy,Boronophenylalanine,Head and neck cancer,Radiotherapy,